2024, Volume 31 (online first)

2024, Volume 31, Issue 4, pages 121–160

Editorials Clinical articles News and views
Topics include:-
  • Cardiorenal benefits of newer diabetes therapies
  • Grüntzig's technique, relearnt
  • Assessment of donor heart echocardiography pathway
  • Nurse-led radial access programme

Editorials

Back to top

Clinical articles

Back to top

December 2024 Br J Cardiol 2024;31(4) doi:10.5837/bjc.2024.055

A case of myocarditis and associated atrioventricular heart block: a diagnostic conundrum

Louis Graham-Hart, Wai Nyunt Thinn, Kaushik Guha

Abstract

The combination of atrioventricular (AV) block – specifically high-grade AV block– within the setting of myocarditis, is a rarely encountered clinical phenomenon. It is commonly encountered in infiltrative cardiomyopathies but may be associated with myocarditis.

Beyond conventional investigation and consideration of endomyocardial biopsy, there is a paucity of data to guide clinicians with regards to the issue of heart rhythm disorder. Options include a ‘watch-and-wait’ policy, anti-arrhythmic drugs, consideration of a permanent pacemaker or, alternatively, a wearable or implantable cardioverter-defibrillator (ICD).

The case encapsulates the difficulties facing clinicians with such pathology and the need to further investigate and risk stratify such patients.

| Full text

December 2024 Br J Cardiol 2024;31(4) doi:10.5837/bjc.2024.056

A rare case of hypereosinophilic endomyocardial fibrosis due to PCM1-JAK2

Hannah Cooke, Amy Burchell

Abstract

Endomyocardial fibrosis is a common cause of restrictive cardiomyopathy worldwide, but rarely occurs in patients living outside tropical regions.1 Herein is the first published case report of a 48-year-old woman with endomyocardial fibrosis due to hypereosinophilia secondary to a rare chromosome 8 and 9 PCM1-JAK2 translocation.

| Full text

December 2024 Br J Cardiol 2024;31(4) doi:10.5837/bjc.2024.057

A tale of two hearts

Amar Ahmed, Waqas Akhtar, Tarun Mittal, David Jones, Fernando Riesgo Gil, Andrew Morley-Smith, Owais Dar

Abstract

A 74-year-old man with a heterotopic heart transplant experienced alternating episodes of sustained native heart ventricular tachycardia and prolonged asystole. These were managed with cardioversion, drug therapy and pacemaker insertion. The unique physiology in such patients lends itself to numerous clinical considerations that would otherwise be routine management for most.

| Full text

November 2024 Br J Cardiol 2024;31(4) doi:10.5837/bjc.2024.049

Tricuspid valve endocarditis presenting as multifocal cavitating pneumonia

Arun Kumar Baral, Michael Connolly

Abstract

A young man with multifocal cavitating pneumonia presented with early abscess formation secondary to Staphylococcus aureus bacteraemia treated with intravenous (IV) flucloxacillin. Further workup with transthoracic echocardiography revealed a large vegetation on the tricuspid valve with at least moderate tricuspid regurgitation; however, there were no peripheral stigmata of infective endocarditis. There was no history of intravenous drug use, but he had a history of administering frequent intramuscular recreational steroid injections. He also had a recent history of a loose tooth. In addition, there were multiple skin excoriations from scratching related to anxiety. Transoesophageal echocardiography confirmed two vegetations on the tricuspid valve, the largest measuring 21 mm with evidence of severe tricuspid regurgitation. The findings were discussed in the cardiac surgery multidisciplinary meeting and the consensus was for initial sterilisation with IV antibiotics followed by surgery.

| Full text

November 2024 Br J Cardiol 2024;31(4) doi:10.5837/bjc.2024.050

Transient T-wave oversensing as a result of COVID-19: a case report

Zeyad Khalil, Dixon Ward, Cristiana Ribiero, Antony French

Abstract

This case report explores the effects of myocarditis induced by coronavirus disease 2019 (COVID-19) on a cardiac implanted electronic device (CIED) and its ability to differentiate depolarisation and repolarisation. Through the modification of the device settings, inappropriate CIED discharges were prevented for the duration of the illness in this 76-year-old male patient. This provides supporting evidence to consider episodes of acute COVID-19 as a cause for T-wave oversensing (TWOS).

| Full text

October 2024 Br J Cardiol 2024;31(4) doi:10.5837/bjc.2024.044

Subclavian venoplasty for device implantation in a district general hospital: a case series

Muhammad Usman Shah, Kelvin Lee, Hira Yousuf, David Morgan, Juan Fernandez

Abstract

Subclavian venoplasty is commonly performed for subclavian vein stenosis in patients with long-term dialysis lines or fistulae. Such stenosis may also occur in patients with previously implanted intra-cardiac devices. It poses a problem if a further device upgrade or implantation is planned as the stenosis restricts the advancement of leads. Venoplasty before device implantation may provide a feasible alternative to lead tunnelling or extraction, which have their limitations. Four cases of varying complexities and devices that were implanted in patients with subclavian stenosis are presented herein. These were done in a district general hospital within the cardiology team. Venoplasty was performed using peripheral angioplasty balloons after which the device was implanted. All cases were performed successfully without any immediate complications with the patients discharged home the same day. These cases show the utility of subclavian venoplasty in facilitating device implantation without the need to utilise contralateral venous access, hence preserving venous access for the future. Additionally, they illustrate that this may be performed locally in a district general hospital setting, where appropriate expertise is available, with a high success rate and without the need to refer patients to an alternate tertiary care institute which may be associated with additional difficulties for the patient. To the best of our knowledge, this is the first instance where several cases of this procedure were performed successfully in a secondary care setting.

| Full text

October 2024 Br J Cardiol 2024;31(4) doi:10.5837/bjc.2024.045

Sudden cardiac death associated with a pathogenic genetic variant in HCN4

Gokul Parameswaran, Edward Blair, Hugh C Watkins, Julian OM Ormerod

Abstract

Pathogenic genetic variants in the HCN4 (hyperpolarisation-activated and cyclic nucleotide-gated channel) gene can cause sinus node dysfunction, disrupting the function of the pacemaker region of the heart. Patients with such variants can present with a wide spectrum of arrhythmias but sudden death is generally considered rare. We report two cases from the same family with different outcomes to highlight a potential high-risk phenotype in HCN4-related disease.

| Full text

July 2024 Br J Cardiol 2024;31(3) doi:10.5837/bjc.2024.029

Simultaneous Takotsubo syndrome and spontaneous coronary artery dissection: a case report

Carla Oliveira Ferreira, Cátia Costa Oliveira, Carlos Galvão Braga, Jorge Marques

Abstract

A 59-year-old woman presented to the emergency room with sudden onset of retrosternal thoracic pain following emotional stress. The electrocardiogram (ECG) revealed T-wave inversions on precordial leads. Her blood analyses demonstrated elevation of myocardial necrosis markers (peak of troponin I of 3.4 ng/ml). Transthoracic echocardiogram (TTE) findings were consistent with Takotsubo syndrome, accompanied by mild left ventricular dysfunction. The patient underwent invasive coronary angiography revealing a spontaneous coronary artery dissection in the left anterior descending artery and left main artery. A repeat TTE one week later showed complete resolution of the segmental contractility with a full recovery of left ventricular function. Cardiac magnetic resonance imaging revealed no abnormalities. The patient was discharged on dual-antiplatelet therapy. A follow-up coronary angiography performed one month later confirmed complete resolution of the dissection. Takotsubo syndrome and spontaneous coronary artery dissection predominantly affect women and share common triggers. This case highlights the often misdiagnosed association and emphasises the specific diagnosis and treatment nuances associated with it.

| Full text

July 2024 Br J Cardiol 2024;31(3) doi:10.5837/bjc.2024.030

Shortness of breath caused by a right ventricular metastasis: a case report

Muhammad Qasim Shahid, Suat Loo

Abstract

Cardiac metastases normally reflect diffuse metastatic spread of the primary tumour and are rarely found in isolation. We present a case of a 71-year-old man with a history of completely resected high-grade spindle cell sarcoma of the left thigh, who presented with shortness of breath, and was found to have a large right ventricular mass, subsequently diagnosed as a metastasis of the prior sarcoma. It was deemed inoperable and incurable, and the patient was offered palliative chemotherapy. Unfortunately, the patient died within four months of his original presentation.

| Full text

News and views

Back to top

December 2024 Br J Cardiol 2024;31(4)

HEART UK’s 37th AMSC 2024 – Hot topics in atherosclerosis and cardiovascular disease

HEART UK held its 37th Annual Medical and Scientific Conference between 10th–12th July. This year, the cholesterol charity took on an international theme, looking...

September 2024 Br J Cardiol 2024;31(3)

British Cardiovascular Society annual conference, 2024: back to the patient

The British Cardiovascular Society (BCS) annual conference returned to the Manchester Central Convention Complex on the 3–5 June 2024. This year’s focus was...

September 2024 Br J Cardiol 2024;31(3) doi:10.5837/bjc.2024.040

Correspondence: Prevention of stroke

Dear Sirs, In the recent article ‘Drug therapies for stroke prevention’, under the heading entitled ‘Control of blood pressure’, the authors specified that...

August 2024 Br J Cardiol 2024;31(3) doi:10.5837/bjc.2024.036

Correspondence: Important safety aspects in SGLT2 inhibitor prescribing in heart failure

Dear Sirs, Sodium-glucose cotransporter type 2 (SGLT2) inhibitors (dapagliflozin, empagliflozin, canagliflozin) are increasingly being prescribed in the primary-care setting for cardiovascular indications. SGLT2...